Effect of cisplatin on triple negative breast cancer

Also available in printed version

التفاصيل البيبلوغرافية
المؤلف الرئيسي: Hend Salaheldien Ahmed Elnour
مؤلفون آخرون: Praseetha Prabhakaran, supervisor
التنسيق: Master's thesis
اللغة:الإنجليزية
منشور في: Universiti Teknologi Malaysia 2025
الموضوعات:
الوصول للمادة أونلاين:https://utmik.utm.my/handle/123456789/52555
Abstract Abstract here
_version_ 1854975068143091712
author Hend Salaheldien Ahmed Elnour
author2 Praseetha Prabhakaran, supervisor
author_facet Praseetha Prabhakaran, supervisor
Hend Salaheldien Ahmed Elnour
author_sort Hend Salaheldien Ahmed Elnour
description Also available in printed version
format Master's thesis
id utm-123456789-52555
institution Universiti Teknologi Malaysia
language English
publishDate 2025
publisher Universiti Teknologi Malaysia
record_format dspace
record_pdf Abstract
spelling utm-123456789-525552025-08-21T00:00:28Z Effect of cisplatin on triple negative breast cancer Hend Salaheldien Ahmed Elnour Praseetha Prabhakaran, supervisor Biosciences and medical engineering Also available in printed version Triple negative breast cancer is a distinct group of breast tumors that is characterized by the lack of expression of hormone receptors including estrogen (ER) and progesterone (PgR) receptors as well as human epidermal growth factor receptor 2 (HER2). This subtype is a high risk breast cancer with the existence of breast cancer stem cells (BCSCs) which is presumed to be more aggressive and difficult to cure. In this in vitro study, the effect of cisplatin as a member of the platinum anticancer drugs in two different breast cancer cell lines, that represent the triple negative (MDA-MB-468) and hormone positive Luminal A (MCF-7) breast cancer subtypes were examined. Cisplatin was used at 5 different concentrations 5, 10, 15, 20 and 25µM, and cell viability was measured using celltiter glo assay while proliferation was measured using the cyquant NF Cell Proliferation Assay. Apoptosis was analyzed via caspase glo R 3/7 assay. The cell viability for MDA-MB-468 cell line started to decline to 85% at dose 20µM of cisplatin and 75% at 25µM of cisplatin while viability in MCF-7 cell lines was reduced to 91% in the highest dose. Cisplatin showed anti proliferation effect for both cell lines started from the lowest concentration of the drug 5µM in MDA-MB-468 cell lines and at concentration of 15µM for MCF-7 cell line. MDA-MB-468 showed changes in cell morphology at the dose of 25µM representing that small numbers of cells were damaged and disturbed in cell shape while MCF-7 showed no changes in cell morphology under the light microscope. Cisplatin at 25µM did not induce apoptosis in MDA-MB-468 cell line in contrast with the control drug taxol at 50nM which induced apoptosis in MDAMB- 468 cell line. It can be concluded that cisplatin inhibits cell growth in a dose dependent manner and subsequent cytotoxicity resulting in morphological changes of the cancer cells, obvious reduction in cell viability and proliferation. Based on the findings, it can be concluded that cisplatin may induce differentiation in TNBCs. However, more investigations are needed to confirm its ability to induce differentiation of breast cancer cells fahmimoksen UTM 66 p. Thesis (Sarjana Sains (Bioteknologi)) - Universiti Teknologi Malaysia, 2017 2025-03-14T07:28:59Z 2025-03-14T07:28:59Z 2017 Master's thesis https://utmik.utm.my/handle/123456789/52555 vital:109604 valet-20180419-151746 ENG Closed Access UTM Complete Unpublished Completion application/pdf Universiti Teknologi Malaysia
spellingShingle Biosciences and medical engineering
Hend Salaheldien Ahmed Elnour
Effect of cisplatin on triple negative breast cancer
thesis_level Master
title Effect of cisplatin on triple negative breast cancer
title_full Effect of cisplatin on triple negative breast cancer
title_fullStr Effect of cisplatin on triple negative breast cancer
title_full_unstemmed Effect of cisplatin on triple negative breast cancer
title_short Effect of cisplatin on triple negative breast cancer
title_sort effect of cisplatin on triple negative breast cancer
topic Biosciences and medical engineering
url https://utmik.utm.my/handle/123456789/52555
work_keys_str_mv AT hendsalaheldienahmedelnour effectofcisplatinontriplenegativebreastcancer